BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao YY, Jia J, Zhang JJ, Xun YP, Xie SJ, Liang JF, Guo HG, Zhu JZ, Ma SL, Zhang SR. Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT. Acta Pharmacol Sin 2021;42:1288-97. [PMID: 33159174 DOI: 10.1038/s41401-020-00548-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Nguyen PL, Cho J. Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets. Biomolecules 2021;11:1232. [PMID: 34439898 DOI: 10.3390/biom11081232] [Reference Citation Analysis]
2 Lorentz A, Bilotta S, Civelek M. Molecular links between allergy and cancer. Trends in Molecular Medicine 2022. [DOI: 10.1016/j.molmed.2022.06.003] [Reference Citation Analysis]
3 Hou R, Liu X, Yang H, Deng S, Cheng C, Liu J, Li Y, Zhang Y, Jiang J, Zhu Z, Su Y, Wu L, Xie Y, Li X, Li W, Liu Z, Fang W. Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression. Cancer Lett 2022:S0304-3835(22)00041-6. [PMID: 35114328 DOI: 10.1016/j.canlet.2022.01.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Czerwiński M, Bednarska-Czerwińska A, Ordon P, Gradzik M, Oplawski M, Boroń D, Zientek H, Ogloszka O, Grabarek BO. Variances in the Expression of mRNAs and miRNAs Related to the Histaminergic System in Endometrioid Endometrial Cancer. Biomedicines 2021;9:1535. [PMID: 34829764 DOI: 10.3390/biomedicines9111535] [Reference Citation Analysis]
5 Chen Y, Ma Y, Feng JJ, Wang YH, Li TF, Nurmi K, Eklund KK, Wen JG. Histamine H3 Receptor Signaling Regulates the NLRP3 Inflammasome Activation in C2C12 Myocyte During Myogenic Differentiation. Front Pharmacol 2021;12:599393. [PMID: 34135750 DOI: 10.3389/fphar.2021.599393] [Reference Citation Analysis]
6 Broad RV, Jones SJ, Teske MC, Wastall LM, Hanby AM, Thorne JL, Hughes TA. Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy. Br J Cancer 2021;124:1110-20. [PMID: 33398063 DOI: 10.1038/s41416-020-01226-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kraus FBT, Topalov NE, Deuster E, Hysenaj I, Mayr D, Chelariu-Raicu A, Beyer S, Kolben T, Burges A, Mahner S, Trillsch F, Jeschke U, Czogalla B. Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer. J Cancer Res Clin Oncol 2022. [PMID: 35751684 DOI: 10.1007/s00432-022-04114-x] [Reference Citation Analysis]